Focus Partners Wealth’s Utah Medical Products UTMD Stock Holding History

Focus Partners Wealth’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$304K	Buy	+4,898	New	+$309K	﹤0.01%	2192

Other funds holding UTMD

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Focus Partners Wealth's UTMD Position: Q1 2026 in Review

Focus Partners Wealth opened a new position in Utah Medical Products (UTMD) in Q1 2026: 4,898 shares worth $304K. The stake represents ﹤0.01% of the portfolio and ranks #2192 among its holdings.

119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

Focus Partners Wealth held 4,898 shares of Utah Medical Products worth $304K as of Q1 2026.
Utah Medical Products was a new Focus Partners Wealth position in Q1 2026.
Utah Medical Products made up ﹤0.01% of Focus Partners Wealth's portfolio in Q1 2026, its #2192 holding.
119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.